We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

New plasminogen activator a patent hope for MI victims

Phil Gunby
JAMA. 1983;250(20):2743-2744. doi:10.1001/jama.1983.03340200003001.
Text Size: A A A
Published online


A little-known substance called tissue-type plasminogen activator (t-PA) has been used to dissolve blood clots in various vessels of at least 15 patients in Europe and the United States.

Plasminogen activators are enzymes that trigger a series of events leading to the breakup of blood clots—particularly important in the coronary arteries. The two best-known exogenous plasminogen activators are streptokinase and urokinase (JAMA [MEDICAL NEWS] 1982;248:805-811).

Now these two have been joined by t-PA. The latter's clinical use in an initial seven patients was revealed at a Houston symposium on Interventional Modifications in Coronary Artery Disease, sponsored by the Texas Heart Institute, by Désiré Collen, MD, PhD, of the University of Leuven, Belgium. All vessels treated were still patent, he said. There are now informal reports that recanalization has also been achieved in at least eight other patients.

Collen spoke of clinical work involving the seven patients, without elaborating further, during


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.